Pharmaxis is a specialist pharmaceutical company engaged in research, development and commercialisation of new therapies for chronic respiratory diseases and auto immune diseases. Its patented products include Bronchitol and Aridol. Pharmaxis is headquartered in Sydney, Australia with additional offices in the US, UK and China.
Registrars: |
Address: | |
Phone: | |
Fax: | |
Website: | |
Email: |
ISIN: | AU000000PXS5 |
Main Indices: | ASX All Ordinaries |